Fuad El-Hibri — Founder and Executive Chairman at Emergent Biosolutions | Comparably
Emergent Biosolutions Claimed Company
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. read more
EMPLOYEE
PARTICIPANTS
22
TOTAL
RATINGS
390
HR or Marketing? Claim Your Free Employer Account
Fuad El-Hibri — Founder and Executive Chairman at Emergent Biosolutions

Fuad El-Hibri — Founder and Executive Chairman at Emergent Biosolutions

Executive Bio

Mr. Fuad El-Hibri served as Chief Executive Officer of Emergent Biodefense Operations Lansing Inc., a subsidiary of Emergent Biosolutions Inc. since June 2004. Mr. El-Hibri founded Emergent Biosolutions, Inc. in 1998 and has been its Executive Chairman and Director since June 2004 and April 2004 respectively. He served as Chief Executive Officer of Emergent Biosolutions Inc. from June 2004 to March 2012. He served as the President of Emergent BioSolutions, Inc. from March 2006 to April 2007. He is a successful business entrepreneur with extensive experience in telecommunications and the bio-pharmaceutical industry. He served as Chairman and Chief Executive Officer of BioPort Corporation from May 1998 to June 2004. He served as president of Digicel from August 2000 to February 2005. Mr. El-Hibri served as the President of East West Resources Corporation from September 1990 to January 2004. He has an extensive background in telecommunications and biopharmaceuticals. He developed and Co-managed the first digital cellular operating network in Russia, assisted a major European telecommunications operator to prepare a bid and win the mobile GSM tender in Poland and founded and managed a cellular operating company Venezuela and a cellular network in El Salvador. He was a Member of the Senior Management Team of Speywood, LTD. and organized and directed the management buyout of Porton Products Ltd. He reorganized Porton and was advisor to the senior management team involved in the oversight of operations. Mr.El-Hibri was instrumental in marketing and distributing two types of biodefense vaccines in the early nineties. He served as a Senior Associate and Resident Project Manager at Booze-Allen & Hamilton and as a Manager of CitiCorp. in New York (Mergers and Acquisitions), and in Jeddah, Saudi Arabia (Operations and Credit). Mr. El-Hibri has been Chairman of East West Resources Corporation since June 1990. He has been Chairman and Director of Aptevo Therapeutics Inc. since August 1, 2016. He serves as Chairman and Treasurer of El-Hibri Charitable Foundation. He served as the executive chairman of Emergent's board of directors since April 2012. He served as Chairman of Emergent Biodefense Operations Lansing Inc. He served as the Chairman of Digicel Holdings from August 2000 to October 2006. He also served as Chairman and Director of Digicel El Salvador. He has been a Director of Emergent BioSolutions, Inc. since April 2004. He served as Director of Emergent BioDefense Operations Lansing Inc. He serves as a Director of U.S. Chamber of Commerce. Mr. El-Hibri serves as a member of the board of trustees of American University, a member of the board of directors of the International Biomedical Research Alliance, an academic joint venture among the National Institutes of Health, or NIH, Oxford University and Cambridge University and a member of the board of trustees of the National Health Museum, a non-profit institution developing a museum of health sciences. He served as a Director of Speywood Holdings, Ldt. Mr. El-Hibri earned a Masters Degree in Public and Private Management from Yale University and a BA Degree with Honors in Economics from Stanford University.
Name
Title
Salary
Total Comp Total Compensation includes both short-term and long-term benefits, option grants, salary, bonuses, company perks, etc. that can be used to determine financial benefits. An executive may or may not realize all of the Total Co mpensation during their tenure at the Company. Values of the benefits may change over time.
Founder and Executive Chairman
$964k
$2.43M

Executive Team Culture Ratings from Emergent Biosolutions Employees

TOP
25%
Emergent Biosolutions' Executive Team scores in the Top 25%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Gender - Male 66/100
Who ranks the Executive Team the lowest?
Not Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Emergent Biosolutions

Emergent Biosolutions' Executive Team at a Glance

Based on 19 ratings, Emergent Biosolutions' employees are satisfied with their Executive Team and give them a ā€œBā€ or 73/100.

Emergent Biosolutions' Executive Team ranks in the Top 30% of other companies in Washington, DC and Top 25% of other companies on Comparably that also have 1,001-5,000 Employees.

×
Rate your company